R7V-28208-99254
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 952 / CA
- Registered
- 2021-10-05
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-10-04
Dose 3 — Pfizer-BioNTech
-
2021-10-05
Registered in v-safe
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-11-15
-
2022-01-05
Survey response — 3 months, dose 3MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | No |
| 2 | 2021-02-20 | Pfizer-BioNTech | No |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release